Qureos

SEAPORTS THERAPEUTICS

القطاع غير محدد
الموقعUnited States
حجم الشركةغير محدد

عن الشركة

Seaport Therapeutics (Nasdaq: SPTX) is a clinical-stage biopharmaceutical company focused on developing novel oral medicines for neuropsychiatric disorders like depression and anxiety. Spun out of PureTech Health, the Boston-based company went public in May 2026, raising $254.9 million in an upsized initial public offering

وظيفة واحدة في SEAPORTS THERAPEUTICS